05/10/2022 / By Ethan Huff
Sen. Dick Durbin (D-Ill.) is once again launching an assault on dietary supplements.
His new “Dietary Supplement Listing Act of 2022,” which was introduced with Sen. Mike Braun (R-Ind.), threatens to eliminate access to therapeutic doses of dietary supplements, which tens of millions of Americans rely on for their health.
“The bill threatens fines and jailtime for companies that do not comply,” warns the Alliance for Natural Health – USA. “If a company does not submit the proper information, in the correct form, by the proper date, the supplement is considered misbranded.”
“For the first offense, violators can be imprisoned for one year and fined $1,000 dollars; for the second offense, violators can be imprisoned for three years and fined $10,000. Given the safety record of supplements that will be detailed below, the punishments here hardly seem to fit the crime.”
Durbin’s bill puts both consumers and supplement companies in a lose-lose situation. In order to avoid fines and jail time, supplement companies will have to comply with it. Doing so will ultimately lead to their demise, though.
According to ANH-USA, the FDA will use the information it receives via compliance to sweep the market of as many as 41,000 supplements that do not comply with its egregious “new supplement” guidance.
“Supplement companies lose, the economy suffers, and consumers lose access to critical health products,” the group warns. (Related: Durbin has tried but failed to do this same thing before, so let’s be sure to stop him once again!)
To make matters worse, another Democrat, Sen. Patty Murray of Washington, is pushing a similar provision from a different angle, which ANH-USA says will double the chances that Durbin’s bill passes.
Murray, who chairs the Senate Health, Education, Labor, and Pensions (HELP) Committee, is independently planning to attach a similar mandatory product registration provision for dietary supplements to the reauthorization of the Prescription Drug User Fee Act, which must pass by the end of September.
None of this is even remotely necessary, seeing as how dietary supplements are about the safest thing you can take – far safer, in fact, than FDA-approved pharmaceuticals, which kill hundreds of thousands of people every single year.
“That supplements are the products getting federal attention speaks to the power of the drug industry lobby and the willingness of elected officials and FDA officials to do their bidding,” says ANH-USA. “We cannot let these forces succeed in undermining our ability to stay healthy, naturally.”
This is an urgent matter that must be dealt with immediately in preservation of dietary supplement freedom in the United States. If Durbin’s bill and Murray’s provision make it through the legislative process, it will be game over for dietary supplement freedom in the “land of the free.”
“A well-organized, coordinated campaign from the FDA and Big Pharma is threatening access to the supplements you depend on,” ANH-USA says.
“Using the false premise that supplements are unsafe, the FDA is working to gain more power over the regulation of supplements in order to further solidify Big Pharma’s monopoly over medicine. These efforts must be opposed.”
ANH-USA has created a simple Action Alert page that you can use to write Congress and tell them to OPPOSE any and all “mandatory filing” requirements for dietary supplements.
It is recommended that you personalize the message if you are able, explaining how dietary supplements have helped you and those you love, and how a mandatory filing requirement that pulls supplements off the market will harm your health and the health of your loved ones.
To learn more about how dietary supplements are helping people, visit SupplementsReport.com.
Sources for this article include:
Tagged Under:
action alert, alternative medicine, big government, Big Pharma, conspiracy, democrats, Dick Durbin, Dietary Supplement Listing Act of 2022, health freedom, medical fascism, Medical Tyranny, Mike Braun, natural medicine, nutraceuticals, products, smeared, supplements
This article may contain statements that reflect the opinion of the author
COPYRIGHT © 2017 FDA NEWS